ESICM Lives 2019
New data on hemoadsorption with CytoSorb in critically ill patients
Chair: JL Vincent, Brüssel, Belgien & M Singer, London, UK

Improved outcome of patients in septic shock
C Ince, Rotterdam, Niederlande

Advantages of CytoSorb compared to other liver support systems
J Stange, Rostock, Deutschland

What makes it unique? Rationale of CytoSorb
J Kellum, Pittsburgh, USA

Drug removal and safety aspects – What do we currently know
Z Molnar, Szeged, Ungarn

Improved outcome of patients in septic shock
C Ince, Rotterdam, Niederlande

Advantages of CytoSorb compared to other liver support systems
Jan Stange, Rostock, Germany